Interestingly, by competing with nNOS for binding to PSD-95, the nNOS-N1–133 peptide effectively limited the interaction between PSD-95-nNOS and reduced the brain damage after stroke [45, 46]. This evidence concerns the gene DLG4 and stroke disorder.